ABT-431, a selective D1 agonist has efficacy in patients with Parkinson's disease

被引：0
|
作者：
Rascol, O
Blin, O
Descombes, S
Soubrouilliard, C
Fabre, N
Viallet, F
Thalamas, C
Azulay, JP
Lafnitzegger, K
Fredrick, E
Wright, S
Nutt, J
机构：
来源：
NEUROLOGY | 1997年 / 48卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：32004 / 32004
页数：2
相关论文
共 50 条
  • [41] Specificity of striatal dopamine D1 system in humans: implications for clinical use of D1 receptor-agonists in Parkinson's disease
    Goto, Satoshi
    [J]. FRONTIERS IN HUMAN NEUROSCIENCE, 2023, 17
  • [42] Choosing the right dopamine agonist for patients with Parkinson's disease
    Lebrun-Frenay, C
    Borg, M
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (04) : 209 - 214
  • [43] Sumanirole, a highly dopamine D2-selective receptor agonist:: In vitro and in vivo pharmacological characterization and efficacy in animal models of Parkinson's disease
    McCall, RB
    Lookingland, KJ
    Bédard, PJ
    Huff, RM
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 314 (03): : 1248 - 1256
  • [44] Dopamine agonist monotherapy utilization in patients with Parkinson's disease
    Frazer, Monica
    Arcona, Steve
    Le, Lisa
    Sasane, Rahul
    [J]. CLINICAL PARKINSONISM & RELATED DISORDERS, 2023, 8
  • [45] Dopamine D1 receptor expression in human basal ganglia and changes in Parkinson's disease
    Hurley, MJ
    Mash, DC
    Jenner, P
    [J]. MOLECULAR BRAIN RESEARCH, 2001, 87 (02): : 271 - 279
  • [46] Characterizing fucoxanthin as a selective dopamine D3/D4 receptor agonist: Relevance to Parkinson's disease
    Paudel, Pradeep
    Seone, Su Hui
    Jung, Hyun Ah
    Choi, Jae Sue
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 2019, 310
  • [47] The selective dopamine D1 receptor agonist SKF81297 modulates NMDA receptor currents independently of D1 receptors
    Nesbit, Maya O.
    Chai, Anping
    Axerio-Cilies, Peter
    Phillips, Anthony G.
    Wang, Yu Tian
    Held, Katharina
    [J]. NEUROPHARMACOLOGY, 2022, 207
  • [48] Zonisamide has beneficial effects on Parkinson's disease patients
    Murata, M
    Horiuchi, E
    Kanazawa, I
    [J]. NEUROSCIENCE RESEARCH, 2001, 41 (04) : 397 - 399
  • [49] A-86929 - A SELECTIVE DOPAMINE D1 RECEPTOR AGONIST EFFICACIOUS IN RODENT AND PRIMATE MODELS OF PARKINSONS-DISEASE
    ASIN, KE
    NIKKEL, A
    BEDNARZ, L
    DOMINO, EF
    SHIOSAKI, K
    [J]. FASEB JOURNAL, 1995, 9 (03): : A395 - A395
  • [50] Discovery of LY3154207, a potent and selective dopamine receptor D1 positive allosteric modulator for the treatment of Parkinson's disease dementia
    Hao, Junliang
    Beck, James
    Krushinski, Joseph
    Schaus, John
    Wang, Xu-shan
    Heinz, Beverly
    Bruns, Robert
    Bender, David
    Cramer, Jeffery
    Svensson, Kjell
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
12345